A detailed history of Schulhoff & CO Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Schulhoff & CO Inc holds 22,414 shares of BMY stock, worth $1.31 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
22,414
Previous 22,414 -0.0%
Holding current value
$1.31 Million
Previous $930,000 24.62%
% of portfolio
0.52%
Previous 0.45%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$40.25 - $52.99 $20,125 - $26,495
-500 Reduced 2.18%
22,414 $930,000
Q1 2024

May 01, 2024

SELL
$47.98 - $54.4 $1,919 - $2,176
-40 Reduced 0.17%
22,914 $1.24 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $72,362 - $80,912
-1,250 Reduced 5.16%
22,954 $1.33 Million
Q2 2023

Aug 01, 2023

BUY
$63.71 - $70.74 $11,658 - $12,945
183 Added 0.76%
24,204 $1.55 Million
Q1 2022

May 09, 2022

SELL
$61.48 - $73.72 $9,222 - $11,058
-150 Reduced 0.62%
24,021 $1.75 Million
Q3 2021

Nov 08, 2021

SELL
$59.17 - $69.31 $8,875 - $10,396
-150 Reduced 0.62%
24,171 $1.43 Million
Q2 2021

Aug 03, 2021

SELL
$61.91 - $67.42 $6,191 - $6,742
-100 Reduced 0.41%
24,321 $1.63 Million
Q4 2020

Feb 08, 2021

SELL
$57.74 - $65.43 $55,892 - $63,336
-968 Reduced 3.81%
24,421 $1.51 Million
Q3 2020

Nov 04, 2020

SELL
$57.43 - $63.64 $12,921 - $14,319
-225 Reduced 0.88%
25,389 $1.53 Million
Q4 2019

Jan 31, 2020

SELL
$49.21 - $64.19 $8,119 - $10,591
-165 Reduced 0.64%
25,614 $1.64 Million
Q3 2019

Nov 01, 2019

SELL
$42.77 - $50.71 $67,362 - $79,868
-1,575 Reduced 5.76%
25,779 $1.31 Million
Q1 2019

Apr 24, 2019

BUY
$45.12 - $53.8 $57,979 - $69,133
1,285 Added 4.93%
27,354 $1.31 Million
Q4 2018

Feb 07, 2019

SELL
$48.76 - $63.23 $27,110 - $35,155
-556 Reduced 2.09%
26,069 $1.36 Million
Q3 2018

Nov 07, 2018

SELL
$55.19 - $62.25 $5,519 - $6,225
-100 Reduced 0.37%
26,625 $1.65 Million
Q2 2018

Aug 03, 2018

SELL
$50.53 - $62.98 $97,320 - $121,299
-1,926 Reduced 6.72%
26,725 $1.48 Million
Q1 2018

Apr 26, 2018

SELL
$59.92 - $68.98 $6,890 - $7,932
-115 Reduced 0.4%
28,651 $1.81 Million
Q4 2017

Jan 26, 2018

SELL
$59.94 - $65.35 $5,094 - $5,554
-85 Reduced 0.29%
28,766 $1.76 Million
Q3 2017

Oct 25, 2017

SELL
$55.23 - $63.74 $5,523 - $6,374
-100 Reduced 0.35%
28,851 $1.84 Million
Q2 2017

Aug 08, 2017

BUY
N/A
28,951
28,951 $1.61 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Schulhoff & CO Inc Portfolio

Follow Schulhoff & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schulhoff & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schulhoff & CO Inc with notifications on news.